Søgeresultater - Allison P. Jacob

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    RANK and RANK ligand expression in primary human osteosarcoma

    RANK and RANK ligand expression in primary human osteosarcoma af Daniel Branstetter, Kathy Rohrbach, Liya Huang, R Soriano, Mark Tometsko, Michelle Blake, Allison P. Jacob, William C. Dougall

    Udgivet 2015
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  2. 2
    Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma

    Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma af Rahul Lakhotia, Christopher Melani, Kieron Dunleavy, Stefania Pittaluga, Nakhle S. Saba, Liza Lindenberg, Esther Mena, Ethan Bergvall, Andrea N. Lucas, Allison P. Jacob, Erik Yusko, Seth M. Steinberg, Elaine S. Jaffe, Adrian Wiestner, Wyndham H. Wilson, Mark Roschewski

    Udgivet 2022
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  3. 3
    SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm

    SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm af Kevin J. Hamblett, Allison P. Jacob, Jesse L. Gurgel, Mark Tometsko, Brooke M. Rock, Sonal Patel, Robert R. Milburn, Sophia Siu, Seamus P. Ragan, Dan A. Rock, Christopher J. Borths, Jason O’Neill, Wesley Chang, Margaret F. Weidner, Matthew M. Bio, Kim Quon, William C. Fanslow

    Udgivet 2015
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  4. 4
    Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial

    Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional T... af Matthew J. Frank, Nasheed Hossain, Ali Bukhari, Erin Dean, Jay Y. Spiegel, Gursharan K. Claire, Ilan Kirsch, Allison P. Jacob, Chelsea Mullins, Lik Wee Lee, Katherine A. Kong, Juliana Craig, Crystal L. Mackall, Aaron P. Rapoport, Michael D. Jain, Saurabh Dahiya, Frederick L. Locke, David B. Miklos

    Udgivet 2021
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  5. 5
    CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR–refractory large B-cell lymphoma

    CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR–refractory large B-cell lymphoma af John H. Baird, Matthew J. Frank, Juliana Craig, Shabnum Patel, Jay Y. Spiegel, Bita Sahaf, Jean Oak, Sheren Younes, Michael G. Ozawa, Eric Yang, Yasodha Natkunam, John Tamaresis, Zachary Ehlinger, Warren D. Reynolds, Sally Arai, Laura Johnston, Robert Lowsky, Everett Meyer, Robert S. Negrin, Andrew R. Rezvani, Parveen Shiraz, Surbhi Sidana, Wen‐Kai Weng, Kara L. Davis, Sneha Ramakrishna, Liora M. Schultz, Chelsea Mullins, Allison P. Jacob, Ilan Kirsch, Steven A. Feldman, Crystal L. Mackall, David B. Miklos, Lori Muffly

    Udgivet 2020
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  6. 6
    Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma

    Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma af Christopher Melani, Rahul Lakhotia, Stefania Pittaluga, James D. Phelan, Da Wei Huang, George W. Wright, Jillian Simard, Jagan Muppidi, Craig J. Thomas, Michele Ceribelli, Frances A. Tosto, Yandan Yang, Weihong Xu, Theresa Davies‐Hill, Svetlana Pack, Cody J. Peer, Oluwatobi Arisa, Esther Mena, Liza Lindenberg, Ethan Bergvall, Craig A. Portell, Rafic Farah, Seung‐Tae Lee, Amynah Pradhan, Candis Morrison, Atekelt Tadese, Anna Marie Juanitez, Crystal Lu, Allison P. Jacob, Heidi Simmons, William D. Figg, Seth M. Steinberg, Elaine S. Jaffe, Mark Roschewski, Louis M. Staudt, Wyndham H. Wilson

    Udgivet 2024
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  7. 7
    Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: a multicentre, single-arm, phase 2 trial

    Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphoc... af Jacob D. Soumerai, Anthony R. Mato, Ahmet Doǧan, Venkatraman Seshan, Erel Joffe, K. T. Flaherty, Jason Carter, Ephraim P. Hochberg, Jeffrey A. Barnes, Audrey M. Hamilton, Jeremy S. Abramson, Connie Lee Batlevi, Matthew J. Matasar, Ariela Noy, Colette Owens, M. Lia Palomba, Anita Kumar, Tak Takvorian, Ai Ni, Morgan Choma, Chaya Friedman, Puja Chadha, Elizabeth Simkins, Jade Ruiters, Sidney Sechio, Daneal Portman, Lauren Ramos, Natascha Nolet, Neena Mahajan, Rosalba Martignetti, Joanna Mi, Krista J. Scorsune, Julia Lynch, Brianne McGree, Stephanie Hughes, Clare Grieve, Lindsey E. Roeker, Meghan C. Thompson, P. Connor Johnson, Mikhail Roshal, Jane Huang, Juliana Biondo, Qun Wu, Allison P. Jacob, Omar Abdel‐Wahab, Andrew D. Zelenetz

    Udgivet 2021
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  8. 8
    LONG‐TERM FOLLOW‐UP OF MULTICENTER PHASE II TRIAL OF ZANUBRUTINIB, OBINUTUZUMAB, AND VENETOCLAX (BOVEN) IN PREVIOUSLY UNTREATED PATIENTS WITH CLL/SLL

    LONG‐TERM FOLLOW‐UP OF MULTICENTER PHASE II TRIAL OF ZANUBRUTINIB, OBINUTUZUMAB, AND VENETOCLAX (BOVEN) IN PREVIOUSLY UNTREATED PATIENTS WITH CLL/SLL af Jacob D. Soumerai, Ahmet Doǧan, Venkatraman Seshan, K. T. Flaherty, J. Carter, Ephraim P. Hochberg, Jeffrey A. Barnes, Jeremy S. Abramson, Amber Hamilton, Ariela Noy, C. N. Owens, M. Lia Palomba, Anita Kumar, Lindsey E. Roeker, Meghan C. Thompson, Ronald W. Takvorian, Zachary D. Epstein‐Peterson, Mark B. Geyer, W. Ramos‐Amador, Neena Mahajan, Rosalba Martignetti, Sue Plummer, Jia Mi, J. M. Lynch, Brianne McGree, M. M. Sherburne, E. N. Patterson, Natalie Slupe, Maria Chabowska, A. Labarre, Theodore J. Choma, G. McCambridge, Hillary R. Kelly, Margaret Devlin, Madeline Puccio, R. García, Clare Grieve, A. Cohen, Juliana Biondo, Allison P. Jacob, Omar Abdel‐Wahab, Andrew D. Zelenetz

    Udgivet 2023
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  9. 9
    CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

    CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial af Jay Y. Spiegel, Shabnum Patel, Lori Muffly, Nasheed Hossain, Jean Oak, John H. Baird, Matthew J. Frank, Parveen Shiraz, Bita Sahaf, Juliana Craig, María Iglesias, Sheren Younes, Yasodha Natkunam, Michael G. Ozawa, Eric Yang, John Tamaresis, Harshini Chinnasamy, Zachary Ehlinger, Warren D. Reynolds, Rachel C. Lynn, Maria Caterina Rotiroti, Nikolaos Gkitsas, Sally Arai, Laura Johnston, Robert Lowsky, Robbie G. Majzner, Everett Meyer, Robert S. Negrin, Andrew R. Rezvani, Surbhi Sidana, Judith A. Shizuru, Wen‐Kai Weng, Chelsea Mullins, Allison P. Jacob, Ilan Kirsch, Magali Bazzano, Jing Zhou, Sean Mackay, Scott J. Bornheimer, Liora M. Schultz, Sneha Ramakrishna, Kara L. Davis, Katherine A. Kong, Nirali N. Shah, Haiying Qin, Terry J. Fry, Steven A. Feldman, Crystal L. Mackall, David B. Miklos

    Udgivet 2021
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: